Display options
Cite
Cummings, J., Lee, G., Ritter, A., Sabbagh, M., & Zhong, K. (2019). Alzheimer's disease drug development pipeline: 2019. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 5, 272-293.
Cummings, Jeffrey, et al. "Alzheimer's disease drug development pipeline: 2019." Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 (2019): 272-293.
Copy Download .nbib Format: MLA
Share it on
Full text links
View full text

J Cummings, G Lee, A Ritter, M Sabbagh… - Alzheimer's & Dementia …, 2019 - Elsevier

Alzheimer's disease drug development pipeline: 2019.

pipeline programs

Cummings, Sabbagh

GSID: 7wsf4B2228IJ

Excerpt

… Alzheimer's disease (AD) has few available treatments, and there is a high rate of failure in AD drug development programs. Study of the AD drug development pipeline can provide insight into the evolution of drug development and how best to optimize development practices. …

Similar articles

Cited by